Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

PAR made substantial progress in its Phase 3 clinical trial preparations for the treatment of knee osteoarthritis (OA) with ...

Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning.

This study sought to assess predictors of financial toxicity in early-phase clinical trial participants. Age, education level, and income are significant predictors of financial toxicity in patients ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The FDA has lifted clinical holds on trials of zevor-cel, satri-cel, and CT071, and trials will now resume in the US.

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.